Cargando…
A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy
Tumor requires tumor vasculature to supply oxygen and nutrients so as to support its continued growth, as well as provide a main route for metastatic spread. In this study, a TF-cascade-targeted strategy aiming to disrupt tumor blood vessels was developed by combination of TF-targeted HMME-loaded dr...
Autores principales: | Shi, Wei, Yin, Yanxue, Wang, Yao, Zhang, Bo, Tan, Pei, Jiang, Ting, Mei, Heng, Deng, Jun, Wang, Huafang, Guo, Tao, Pang, Zhiqing, Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458279/ https://www.ncbi.nlm.nih.gov/pubmed/27793028 http://dx.doi.org/10.18632/oncotarget.12922 |
Ejemplares similares
-
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy
por: Shi, Wei, et al.
Publicado: (2018) -
EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference
por: Chen, Chen, et al.
Publicado: (2013) -
EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis
por: Wu, Zhilin, et al.
Publicado: (2019) -
Tissue Factor-Targeted “O(2)-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma
por: Li, Ziying, et al.
Publicado: (2020) -
EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2− shRNA to atherosclerotic macrophage in vitro
por: Wu, Zhilin, et al.
Publicado: (2020)